HIRSCHMAN ORIN 13D and 13G filings for Larimar Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2020-06-05 4:18 pm Purchase |
2020-06-02 | 13G | Larimar Therapeutics, Inc. LRMR |
HIRSCHMAN ORIN | 105,650 0.700% |
105,650![]() (New Position) |
Filing |